Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Annemieke Aartsma-Rus is active.

Publication


Featured researches published by Annemieke Aartsma-Rus.


Journal of neuromuscular diseases | 2014

Prolonged Ambulation in Duchenne Patients with a Mutation Amenable to Exon 44 Skipping.

J.C. van den Bergen; H.B. Ginjaar; Erik H. Niks; Annemieke Aartsma-Rus; J. Verschuuren

Duchenne muscular dystrophy has a severe disease course, though variability exists. Case reports suggest a milder disease course of patients amenable to exon 44 skipping. In this study, we analyzed this and show that age at wheelchair dependence in patients with a dystrophin deletion requiring exon 44 skipping is postponed compared to patients with a deletion skippable by exon 45, 51 and 53 (10.8 versus 9.8 years; P 0.020). This may be explained by more frequent spontaneous exon 44 skipping in patients with a deletion flanking exon 44. This finding has important implications for the development of future Duchenne trials.


PLOS ONE | 2017

Natural disease history of mouse models for limb girdle muscular dystrophy types 2D and 2F

S. Pasteuning-Vuhman; K. Putker; C. Tanganyika-de Winter; J. W. Boertje-van der Meulen; L. van Vliet; M. Overzier; Jaap J. Plomp; Annemieke Aartsma-Rus; M. van Putten

Limb-girdle muscular dystrophy types 2D and 2F (LGMD 2D and 2F) are autosomal recessive disorders caused by mutations in the alpha- and delta sarcoglycan genes, respectively, leading to severe muscle weakness and degeneration. The cause of the disease has been well characterized and a number of animal models are available for pre-clinical studies to test potential therapeutic interventions. To facilitate transition from drug discovery to clinical trials, standardized procedures and natural disease history data were collected for these mouse models. Implementing the TREAD-NMD standardized operating procedures, we here subjected LGMD2D (SGCA-null), LGMD2F (SGCD-null) and wild type (C57BL/6J) mice to five functional tests from the age of 4 to 32 weeks. To assess whether the functional test regime interfered with disease pathology, sedentary groups were taken along. Muscle physiology testing of tibialis anterior muscle was performed at the age of 34 weeks. Muscle histopathology and gene expression was analysed in skeletal muscles and heart. Muscle histopathology and gene expression was analysed in skeletal muscles and heart. Mice successfully accomplished the functional tests, which did not interfere with disease pathology. Muscle function of SGCA- and SGCD-null mice was impaired and declined over time. Interestingly, female SGCD-null mice outperformed males in the two and four limb hanging tests, which proved the most suitable non-invasive tests to assess muscle function. Muscle physiology testing of tibialis anterior muscle revealed lower specific force and higher susceptibility to eccentric-induced damage in LGMD mice. Analyzing muscle histopathology and gene expression, we identified the diaphragm as the most affected muscle in LGMD strains. Cardiac fibrosis was found in SGCD-null mice, being more severe in males than in females. Our study offers a comprehensive natural history dataset which will be useful to design standardized tests and future pre-clinical studies in LGMD2D and 2F mice.


Human Gene Therapy | 2007

Comparative Analysis of Antisense Oligonucleotide Sequences for Targeted Skipping of Exon 51 During Dystrophin Pre-mRNA Splicing in Human Muscle

Virginia Arechavala-Gomeza; Ian R. Graham; Linda Popplewell; A.M. Adams; Annemieke Aartsma-Rus; Maria Kinali; Jennifer E. Morgan; J.C. Van Deutekom; S.D. Wilton; George Dickson; F. Muntoni


Archive | 2007

Means and method for inducing exon-skipping

Annemieke Aartsma-Rus; Judith Christina Theodora Van Deutekom; Garrit-Jan Boudewijn van Ommen


Archive | 2008

Means and methods for counteracting muscle disorders

Josephus Johannes De Kimpe; Gerardus Johannes Platenburg; Judith Christina Theodora Van Deutekom; Annemieke Aartsma-Rus; Garrit-Jan Boudewijn van Ommen


Archive | 2006

Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secodary rna structure

Judith Christina Theodora Van Deutekom; Annemieke Aartsma-Rus; Garrit-Jan Boudewijn van Ommen


Archive | 2009

Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means

Gerardus Johannes Platenburg; Josephus Johannes De Kimpe; Judith Christina Theodora Van Deutekom; Garrit-Jan Boudewijn van Ommen; Annemieke Aartsma-Rus


Archive | 2011

METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50- 53.

Josephus Johannes De Kimpe; Gerardus Johannes Platenburg; Judith Christina Theodora Van Deutekom; Annemieke Aartsma-Rus; Garrit-Jan Boudewijn van Ommen


Archive | 2010

Methods and compositions for dysferlin exon-skipping

Der Maarel Silvère Maria Van; Ommen Garrit-Jan Boudewijn Van; Annemieke Aartsma-Rus; Isabella Houweling-Gazzoli; Dunnen Johannes Theodorus Den


Archive | 2012

Molecule for treating an inflammatory disorder

Garrit-Jan Boudewijn van Ommen; Annemieke Aartsma-Rus; Judith Christina Theodora Van Deutekom; Josephus Johannes De Kimpe; Joseph Stephan Verbeek; Aliye Seda Ylmaz-Elis

Collaboration


Dive into the Annemieke Aartsma-Rus's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Josephus Johannes De Kimpe

Loyola University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G.J.B. van Ommen

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Melvin Maurice Evers

Loyola University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge